The U.S. Food and Drug Administration (USFDA) has cleared for marketing the first in vitro diagnostic device that tests blood to aid in diagnosing Alzheimer's disease. The Lumipulse ...

VOV.VN - The Ho Chi Minh City Department of Health has withdrawn 70 registrations for medical devices after uncovering ...

Wells Bio Co., Ltd.'(CEO Lee Min-jeon), a subsidiary of the global in vitro diagnostic company 'Access Bio', announced on the ...

The FDA has awarded 510(k) clearance to Fujirebio’s Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio in vitro diagnostic (IVD ...

The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio enables early detection of amyloid plaques through a non-invasive blood ...

The FDA has cleared first blood-based in vitro diagnostic tool for detecting Alzheimer's disease. It is approved for use in ...

The first in vitro diagnostic device that uses blood samples to detect Alzheimer disease has been granted marketing clearance ...

The FDA has cleared the first-ever blood test for early Alzheimer's detection, which the agency says reduces the need for ...

The US Food and Drug Administration today cleared for marketing the first in vitro diagnostic device that tests ...

Lab-on-a-Chip Market grows with demand for miniaturized diagnostics, POC testing, personalized medicine, and rapid disease detection technologies.Austin, May 16, 2025 (GLOBE NEWSWIRE) -- Lab on Chips ...

The global Enteral Feeding Devices Market, valued at US$ 2,796.3 million in 2024, is forecasted to grow at a robust CAGR of 6.0%, reaching US$2,965.1 million in 2025 and an impressive US$3,994.2 ...